Boundless Bio Appoints Peter Krein, Ph.D., as Vice President, Precision Medicine

SAN DIEGO–(BUSINESS WIRE)–Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers, today announced that Peter Krein has been appointed as Vice President of Precision Medicine. “We are thrilled to welcome Peter to our growing team,” said Zachary Hornby, President and Chief Executive Officer of Boundless Bio. “He brings a wealth of expertise in precision medicine strategy and companion dia
Click here to view original post